Carbapenem-resistant Acinetobacter baumannii causing osteomyelitis and infections of skin and soft tissues in hospitals of Medellín, Colombia;Acinetobacter baumannii resistente a carbapenémicos causante de osteomielitis e infecciones de la piel y los tejidos blandos en hospitales de Medellín, Colombia

Biomedica

Volumn 35, Issue 4, 2015, Pages 522-530

  Vanegas, Johanna Marcela ^a   Higuita, Luis Felipe ^a   Vargas, Carlos Andrés ^a   Cienfuegos, Astrid Vanessa ^a   Rodríguez, érika Andrea ^a   Roncancio, Gustavo Eduardo ^b   Jiménez, Judy Natalia ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b CardioVID Clinic   (Colombia)

Author keywords

Acinetobacter baumannii; Carbapenems; Drug resistance; Microbial; Osteomyelitis; Soft tissue infections

Indexed keywords

BETA LACTAMASE; BETA-LACTAMASE OXA-23; BETA-LACTAMASE OXA-51, ACINETOBACTER BAUMANNII;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; CHILD; COLOMBIA; CROSS INFECTION; CROSS-SECTIONAL STUDY; DRUG EFFECTS; ENZYMOLOGY; FEMALE; GENETICS; HOSPITAL; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; OPPORTUNISTIC INFECTIONS; OSTEOMYELITIS; PULSED FIELD GEL ELECTROPHORESIS; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS; YOUNG ADULT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CHILD; COLOMBIA; CROSS INFECTION; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HOSPITALS, URBAN; HUMANS; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; OSTEOMYELITIS; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS; YOUNG ADULT;

EID: 84981294529     PISSN: 01204157     EISSN: None     Source Type: Journal    
DOI: 10.7705/biomedica.v35i4.2572     Document Type: Article

References (35)

1. Torres HA, Vázquez EG, Yagüe G, Gómez JG. Multidrug resistant Acinetobacter baumanii: Clinical update and new highlights. Rev Esp Quimioter. 2010;23:12-9.
2. Coyne S, Courvalin P, Périchon B. Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrob Agents Chemother. 2011;55:947-53. http://dx.doi.org/10.1128/AAC.01388-10
3. Gordon NC, Wareham DW. Multidrug-resistant Acinetobacter baumannii: Mechanisms of virulence and resistance. Int J Antimicrob Agents. 2010;35:219-26. http://dx.doi.org/10.1016/j.ijantimicag.2009.10.024
4. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, et al. Bad bugs, no drugs: No ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:1-12. http://dx.doi.org/10.1086/595011
5. Niranjan DK, Singh NP, Manchanda V, Rai S, Kaur IR. Multiple carbapenem hydrolyzing genes in clinical isolates of Acinetobacter baumannii. Indian J Med Microbiol. 2013;31:237-41. http://dx.doi.org/10.4103/0255-0857.115626.
6. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol. 2008;29:1099-106. http://dx.doi.org/10.1086/592412.
7. Woodford N, Turton JF, Livermore DM. Multiresistant Gram-negative bacteria: The role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev. 2011;35:736-5. http://dx.doi.org/10.1111/j.1574-6976.2011.00268.x
8. Hernández C, Blanco V, Motoa G, Correa A, Maya JJ, de la Cadena E, et al. Evolución de la resistencia antimicrobiana de bacilos Gram negativos en unidades de cuidados intensivos en Colombia. Biomédica. 2014;34:91-100. http://dx.doi.org/10.1590/S0120-41572014000500011
9. Grupo para el Estudio de la Resistencia a Antibióticos de Medellín. Acinetobacter baumannii. Fecha de consulta: 6 de octubre de 2014. Disponible en: http://www.grupogermen.org/pdf/Acinetoacter.pdf.
10. Villegas MV, Kattan JN, Correa A, Lolans K, Guzmán AM, Woodford N, et al. Dissemination of Acinetobacter baumannii clones with OXA-23 carbapenemase in Colombian hospitals. Antimicrob Agents Chemother. 2007;51:2001-4. http://dx.doi.org/10.1128/AAC.00226-07
11. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-second Informational Supplement. CLSI document M100-S22. Wayne: Clinical and Laboratory Standards Institute; 2012.
12. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309-32. http://dx.doi.org/10.1016/j.ajic.2008.03.002
13. Esparza G, Ariza B, Bedoya AM, Bustos I, Castañeda CR, De la Cadena E, et al. Estrategias para la implementación y reporte de los puntos de corte CLSI vigentes y pruebas fenotípicas confirmatorias para BLEE y carbapenemasas en bacilos Gram negativos en laboratorios clínicos de Colombia. Infectio. 2013;17:80-9.
14. Thomson KS, Mejglo ZA, Pearce GN, Regan TJ. 3-dimensional susceptibility testing of beta-lactam anti-biotics. J Antimicrob Chemother. 1984;13:45-54. http://dx.doi.org/10.1093/jac/13.1.45
15. Ellington MJ, Kistler J, Livermore DM, Woodford N. Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. J Antimicrob Chemother. 2007;59:321-2. http://dx.doi.org/10.1093/jac/dkl48
16. Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70:119-23. http://dx.doi.org/10.1016/j.diagmicrobio.2010.12.002
17. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents. 2006;27:351-3. http://dx.doi.org/10.1016/j.ijantimicag.2006.01.004
18. Turton JF, Ward ME, Woodford N, Kaufmann ME, Pike R, Livermore DM, et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett. 2006;258:72-7. http://dx.doi.org/10.1111/j.1574-6968.2006.00195.x
19. Bartual SG, Seifert H, Hippler C, Luzon MA, Wisplinghoff H, Rodríguez-Valera F. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol. 2005;43:4382-90. http://dx.doi.org/10.1128/JCM.43.9.4382-4390.2005
20. Guerrero DM, Pérez F, Conger NG, Solomkin JS, Adams MD, Rather PN, et al. Acinetobacter baumannii-associated skin and soft tissue infections: Recognizing a broadening spectrum of disease. Surg Infect (Larchmt). 2010;11:49-57. http://dx.doi.org/10.1089/sur.2009.022
21. Carvalho VC, Oliveira PR, Dal-Paz K, Paula AP, Felix C da S, Lima AL. Gram-negative osteomyelitis: Clinical and microbiological profile. Braz J Infect Dis. 2012;16:63-7. http://dx.doi.org/10.1590/S1413-86702012000100011
22. Grupo para el Estudio de la Resistencia a Antibióticos de Medellín. Frecuencias de microorganismos. Fecha de consulta: 23 de marzo de 2015. Disponible en: http://www.grupogermen.org/pdf/frecuencia.pdf
23. Grupo GREBO. Mayo 5, Día mundial de lavado de manos dedicado a la contención de la resistencia bacteriana. Boletín Informativo GREBO. 2014;6. Fecha de consulta: 23 de marzo de 2015. Disponible en: http://www.grebo.org/grebo_site/jgrebo/documentos/Boletin_Grebo_2014.pdf.
24. Instituto Nacional de Salud. Vigilancia de resistencia bacteriana a través de las bases de datos Whonet, agosto 2014. Fecha de consulta: 23 de marzo de 2015. Disponible en: http://www.ins.gov.co/tramites-y-servicios/examenes-de-inter%C3%A9s-en-salud-publica/Microbiologa/Informe%20de%20resistencia%20Bacteriana%20a%C3%B1o%20%202013.pdf.
25. Lemos EV, De la Hoz-Restrepo F, Alvis N, Quevedo E, Cañón O, León Y. Acinetobacter baumannii-related mortality in intensive care units in Colombia. Rev Panam Salud Pública. 2011;30:287-94. http://dx.doi.org/10.1590/S1020-49892011001000001
26. Prado A, Arias NL, Chávez M, Cabrera CE, Gómez RF. Caracterización fenotípica de aislamientos de Acinetobacter baumannii en una institución de alta complejidad de la ciudad de Cali. Biomédica. 2014;34:101-7. http://dx.doi.org/10.7705/biomedica.v34i0.1666
27. Karah N, Sundsfjord A, Towner K, Samuelsen Ø. Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii. Drug Resist Updat. 2012;15:237-47. http://dx.doi.org/10.1016/j.drup.2012.06.001
28. Aydemir H, Celebi G, Piskin N, Oztoprak N, Keskin AS, Aktas E, et al. Mortality attributable to carbapenem-resistant nosocomial Acinetobacter baumannii infections in a Turkish university hospital. Jpn J Infect Dis. 2012;65: 66-71.
29. Alavi-Moghadam M, Miri M, Mokhtari M, Kouchek M, Goharani R, Sistanzad M, et al. Incidence of imipenem-resistant Acinetobacter baumannii in a general intensive care unit (ICU). Caspian J Intern Med. 2014;5:186-7.
30. Mosqueda N, Espinal P, Cosgaya C, Viota S, Plasensia V, Álvarez-Lerma F, et al. Globally expanding carbapenemase finally appears in Spain: Nosocomial outbreak of Acinetobacter baumannii producing plasmid-encoded OXA-23 in Barcelona, Spain. Antimicrob Agents Chemother. 2013;57:5155-7. http://dx.doi.org/10.1128/AAC.01486-13
31. Opazo A, Domínguez M, Bello H, Amyes SG, González-Rocha G. OXA-type carbapenemases in Acinetobacter baumannii in South America. J Infect Dev Ctries. 2012;6: 311-6. http://dx.doi.org/10.3855/jidc.2310
32. Leski TA, Bangura U, Jimmy DH, Ansumana R, Lizewski SE, Li RW, et al. Identification of blaOXA-51-like, blaOXA-58, blaDIM-1, and blaVIM carbapenemase genes in hospital Enterobacteriaceae isolates from Sierra Leone. J Clin Microbiol. 2013;51:2435-8. http://dx.doi.org/10.1128/JCM.00832-13
33. Martínez P, Mattar S. Imipenem-resistant Acinetobacter baumannii carrying the ISAba1-bla OXA-23, 51 and ISAba1-bla ADC-7 genes in Monteria, Colombia. Braz J Microbiol. 2012;43:1274-80. http://dx.doi.org/10.1590/S1517-83822012000400006
34. Hong SB, Shin KS, Ha J, Han K. Co-existence of blaOXA-23 and armA in multidrug-resistant Acinetobacter baumannii isolated from a hospital in South Korea. J Med Microbiol. 2013;62:836-44. http://dx.doi.org/10.1099/jmm.0.055384-0
35. Tamayo-Legorreta EM, Garza-Ramos U, Barrios-Camacho H, Sánchez-Pérez A, Galicia-Paredes A, Meza-Chávez A, et al. Identification of OXA-23 carbapenemases: Novel variant OXA-239 in Acinetobacter baumannii ST758 clinical isolates in México. New Microbes New Infect. 2014;2;173-4. http://dx.doi.org/10.1002/nmi2.60